Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000876140 | SCV001018668 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193647 | SCV001362623 | benign | not specified | 2019-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372491 | SCV002623951 | likely benign | Cardiovascular phenotype | 2021-02-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001193647 | SCV001921899 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001726359 | SCV001963388 | likely benign | not provided | no assertion criteria provided | clinical testing |